LOW GRADE GLIOMA
Clinical trials for LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill may replace chemo for kids with brain tumor
Disease control Recruiting nowThis study tests whether a targeted drug called selumetinib works as well as standard chemotherapy (carboplatin and vincristine) for children and young adults with a slow-growing brain tumor called low-grade glioma. Participants must be 2 to 21 years old and have a tumor without …
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 14:32 UTC
-
New pill could replace chemo for kids with brain tumor
Disease control Recruiting nowThis study tests a new drug called DAY101 (tovorafenib) against standard chemotherapy in children and young adults under 25 with a type of brain tumor called low-grade glioma that has a specific genetic change (RAF alteration). The goal is to see if DAY101 works better at shrinki…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE3 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 14:31 UTC
-
New pill combo targets Hard-to-Treat BRAF cancers
Disease control Recruiting nowThis study is testing a new oral drug (PF-07799544) alone or with another drug (PF-07799933) in adults with advanced solid tumors that have a BRAF V600 mutation, including melanoma, lung, thyroid, and brain cancers. The goal is to find safe doses and see if the combination shrink…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New vaccine trial offers hope for kids with Hard-to-Treat brain tumors
Disease control Recruiting nowThis study tests a vaccine made from proteins found on glioma cells, combined with an immune booster, in children whose low-grade gliomas have not responded to at least two prior treatments. The goal is to see if the vaccine can shrink the tumor or keep it from growing. About 25 …
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: James Felker • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Brain cancer survivors get a memory boost from home
Symptom relief Recruiting nowThis study tests a home-based program called HOBSCOTCH-CA to help brain cancer survivors improve their memory, thinking, and quality of life. Participants attend weekly virtual coaching sessions and complete short daily tasks on a smartphone app. The study compares two groups: on…
Matched conditions: LOW GRADE GLIOMA
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated May 01, 2026 14:31 UTC
-
Scientists create 'Living Lab' from brain tumors to unlock treatment secrets
Knowledge-focused Recruiting nowThis study collects tumor samples from 50 adults with low- or high-grade glioma to grow mini-tumors (organoids) in the lab. Researchers will compare these organoids to the original tumors to learn why gliomas are hard to treat. The goal is to create personalized 'avatars' for tes…
Matched conditions: LOW GRADE GLIOMA
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC
-
New scan could help doctors see if Kids' brain tumors are responding to treatment
Knowledge-focused Recruiting nowThis study is testing whether a special PET-MRI scan using a tracer called 18F-Fluciclovine can help doctors see how well treatment is working in children and young adults with low-grade gliomas (a type of brain tumor). About 30 participants will get the scan before starting ther…
Matched conditions: LOW GRADE GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC